Literature DB >> 11464837

Responsibilities of sponsors are limited in premature discontinuation of trials.

R Ashcroft.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2001        PMID： 11464837      PMCID： PMC1120687     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility.

Authors:  M Lièvre; J Ménard; E Bruckert; J Cogneau; F Delahaye; P Giral; E Leitersdorf; G Luc; L Masana; P Moulin; P Passa; D Pouchain; G Siest
Journal:  BMJ       Date:  2001-03-10

2.  Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial.

Authors:  S Evans; S Pocock
Journal:  BMJ       Date:  2001-03-10
  2 in total
  3 in total

Review 1.  Stopping trials early for commercial reasons: the risk-benefit relationship as a moral compass.

Authors:  A S Iltis
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

2.  Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons?

Authors:  Peter B Berger; Judson B Williams; Vic Hasselblad; Karen Chiswell; Karen S Pieper; Robert M Califf
Journal:  J Interv Cardiol       Date:  2013-02-05       Impact factor: 2.279

3.  Odon device for instrumental vaginal deliveries: results of a medical device pilot clinical study.

Authors:  Javier A Schvartzman; Hugo Krupitzki; Mario Merialdi; Ana Pilar Betrán; Jennifer Requejo; My Huong Nguyen; Effy Vayena; Angel E Fiorillo; Enrique C Gadow; Francisco M Vizcaino; Felicitas von Petery; Victoria Marroquin; María Luisa Cafferata; Agustina Mazzoni; Valerie Vannevel; Robert C Pattinson; A Metin Gülmezoglu; Fernando Althabe; Mercedes Bonet
Journal:  Reprod Health       Date:  2018-03-12       Impact factor: 3.223
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.